Pembrolizumab in Japanese patients with primary mediastinal large B-cell lymphoma: results from the KEYNOTE-A33 study.
Koji KatoSosuke NakamuraAkira WakanaYasuhiro KohKoji IzutsuPublished in: International journal of clinical oncology (2024)
Registry and the Registration No. of the study/trial: Clinicaltrials.gov: NCT04317066.